⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Coram CVS Specialty Infusion Services and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Coram CVS Specialty Infusion Services
↗Woonsocket, RI, USA
Coram CVS Specialty Infusion Services is a leading provider of home infusion and specialty pharmacy services in the United States. The company specializes in delivering complex therapies, including parenteral and enteral nutrition, immunoglobulin therapy, and various anti-infective and cardiac medications, directly to patients in their homes or at ambulatory infusion suites.
Acquired by CVS Health, Coram operates as a critical component of the CVS Specialty division. While the company has historically provided a broad range of acute and chronic infusion therapies, it has recently undergone strategic adjustments, including the discontinuation of certain acute infusion services to focus on specialty medications and enteral nutrition.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Healthcare Services
Sub-Industry:Home Infusion / Specialty Pharmacy
SIZE & FINANCIALS
Employees:1001-5000
Ownership:subsidiary
Status:operating
STOCK
Exchange:NYSE
Ticker:CVS
PIPELINE
Modalities:Infusion therapy
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:CVS Health
Acquired By:CVS Health (2013-12-01)
Key Partnerships:Janssen Biotech (Infusion site network)
COMPETITION
Position:Leader
Competitors:Option Care Health, Optum Infusion Pharmacy, BioScrip (now part of Option Care Health)
LINKS
Website:coramhc.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Coram CVS Specialty Infusion Services. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.